Hospira Stock Rebounds In Second Quarter; Index Off 1.5%
This article was originally published in The Gray Sheet
Executive Summary
Hospital product manufacturer Hospira's release of stronger-than-expected financial results in the second quarter drove an 8.8% rebound in the firm's stock price to $42.94 for the period - a $3.49 gain over Q1